BMYMP News and Press, Bristol-Myers Squibb $2Pr From 11/21/23

2023-11-21 13:48:38 ET Summary VTRS reported Q3-2023 earnings in line with estimates, with total sales down 3.3%. Adjusted EBITDA fell again, and new product launches are not delivering the same margins as the old business. We look at the progress made since its listing and te...

2023-11-16 12:25:19 ET Summary Pharmaceuticals/biotechnology and life science tools are close to their historical baseline in value and quality. Healthcare equipment is the most overvalued subsector. Ten healthcare stocks cheaper than their peers in November. CURE: Why mos...

2023-11-16 09:36:05 ET Bristol-Myers Squibb Company (BMY) 2023 Jefferies London Healthcare Conference November 16, 2023 4:30 AM ET Company Participants Timothy Power - VP & Head, IR Conference Call Participants Akash Tewari - Jefferies Presentation ...

2023-11-12 06:47:05 ET Bristol-Myers Squibb Company (BMY) 2023 UBS BioPharma Conference Transcript November 8, 2023, 8:00 AM ET Executives Lynelle Hoch - Head, Cell Therapy Analysts Trung Huynh - UBS Presentation Trung Huynh Okay. Itȁ...

2023-11-10 16:05:35 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...

2023-11-06 19:43:49 ET Summary Repare Therapeutics presented preliminary results from the phase 1 MYTHIC study using the lunresertib and camonsertib combination for the treatment of patients with multiple solid tumor types. The biotech plans to complete the phase 1 expansion porti...

2023-11-02 09:00:00 ET Summary Pfizer's stock has dropped due to a decline in revenues post-COVID, presenting a value investment opportunity. The company still generates significant gross profit and has a strong revenue growth rate. Pfizer's low Price-to-Earnings ratio and imp...

2023-10-29 03:30:00 ET Summary Hansoh Pharma sells ex-China rights for its B7-H4 ADC to GSK in a $1.57 billion deal. OrbiMed raises $4.3 billion for three healthcare funds, including $751 million for its OrbiMed Asia V fund. LianBio sells greater China rights for mavacamten to...

2023-10-26 11:36:07 ET Bristol-Myer Squibb Company (BMY) Q3 2023 Earnings Conference Call October 26, 2023 8:00 am ET Company Participants Giovanni Caforio - Chairman, Chief Executive Officer Chris Boerner - Chief Operating Officer David Elkins - Executive Vice P...

2023-10-26 00:58:27 ET Summary In this series, I rank a selection of Dividend Radar stocks and present the ten top-ranked stocks for further research and possible investment. I screened for high-quality stocks with superior growth and income prospects this month. Additionally, I s...